Chronic bloating is one of the most frustrating symptoms a person can live with. It is not dramatic in the way that acute pain is. It does not always show up on standard lab work. And yet for many patients, it is relentless. The distension after meals, the unpredictable discomfort, the sense that something is fundamentally wrong with how your gut is working, despite being told everything looks normal. If that sounds familiar, you are not alone, and there is a clinically recognized explanation worth exploring.
In the Southwest, where heat, dietary patterns, and a high prevalence of prior gastrointestinal infections intersect, functional gut conditions like Small Intestinal Bacterial Overgrowth (SIBO) are increasingly recognized as a root cause of chronic digestive distress. Patients across Scottsdale and the greater Phoenix metro area are seeking answers beyond the standard advice, and the clinical evidence supports a more targeted approach.
This article breaks down what SIBO actually is, what drives it, and what evidence-based treatment options look like, including dietary protocols, herbal antimicrobials, and compounded pharmaceutical approaches tailored to the individual patient.
What SIBO Actually Is
The small intestine is not supposed to be heavily colonized by bacteria. Under normal conditions, the migrating motor complex (MMC), a cyclical pattern of muscular contractions that sweeps the gut between meals, keeps bacterial populations in the small intestine low by moving residual food and microorganisms toward the colon. When this mechanism fails, bacteria that belong in the large intestine migrate upward and establish themselves in the small intestine, where they ferment carbohydrates and produce gas, primarily hydrogen and methane.
The 2020 ACG Clinical Guideline on SIBO defines the condition as an excess of bacteria in the small intestine associated with gastrointestinal symptoms, and notes that breath testing measuring hydrogen and methane production after a fermentable substrate challenge is the most practical diagnostic tool available in clinical practice.1
The symptom overlap between SIBO and irritable bowel syndrome (IBS) is substantial. A review published in Gut and Liver found that SIBO prevalence in IBS patients was considerably higher than in healthy controls, raising the possibility that bacterial overgrowth is a contributing mechanism in many cases previously attributed to functional bowel disorder alone.2
Hydrogen vs. Methane: Why the Distinction Matters
Not all SIBO presents the same way. Hydrogen-dominant SIBO tends to produce diarrhea-predominant symptoms, while methane-dominant overgrowth (sometimes classified separately as intestinal methanogen overgrowth, or IMO) is more commonly associated with constipation and slower gut transit. The North American Consensus on breath testing established standardized protocols for distinguishing between these patterns, which has direct implications for treatment selection.5 Getting the right test, interpreted by a clinician familiar with functional gut medicine, is the necessary first step.
Root Causes and Common Triggers
SIBO does not develop in a vacuum. In most cases, there is an identifiable predisposing factor that disrupts the gut's normal bacterial clearance mechanisms. Understanding that factor is essential for preventing recurrence after treatment.
Migrating Motor Complex Dysfunction
The MMC is the gut's housekeeping mechanism. It activates during fasting periods and generates the muscular wave that clears the small intestine between meals. When MMC function is impaired, whether from prior food poisoning, autoimmune damage to gut nerve cells, or chronic stress, bacteria are not efficiently cleared and begin to accumulate. This is one of the most common underlying drivers of recurrent SIBO.
Low Stomach Acid
Gastric acid serves as a first-line defense against bacterial colonization of the upper GI tract. Hypochlorhydria, whether from long-term proton pump inhibitor use, aging, or H. pylori infection, reduces this barrier and allows bacteria to survive passage through the stomach and establish themselves higher in the digestive tract than they should.
Post-Infectious Gut Dysmotility
Acute gastroenteritis, particularly from organisms like Campylobacter or Salmonella, can trigger an autoimmune response that damages the interstitial cells of Cajal, the pacemaker cells responsible for coordinating gut motility. This post-infectious mechanism is a well-recognized pathway to both IBS and SIBO, and it is worth noting that foodborne illness rates in warm climates like the Phoenix area can be higher during summer months, making this a locally relevant risk factor.
Structural and Anatomical Factors
Adhesions from prior abdominal surgery, strictures, diverticula, and ileocecal valve dysfunction can all create pockets where bacteria accumulate and resist normal clearance. These structural contributors are less amenable to dietary or pharmaceutical intervention alone and may require additional evaluation.
Evidence-Based Treatment Strategies
Effective SIBO treatment is not a single intervention. It is a sequenced approach that addresses bacterial reduction, symptom management during treatment, and root-cause correction to reduce the likelihood of recurrence.
Dietary Protocols: Low-FODMAP as a Bridge
The low-FODMAP diet reduces fermentable carbohydrates that serve as substrate for bacterial fermentation in the small intestine. A landmark review published in Gut confirmed that the low-FODMAP diet significantly reduces bloating, abdominal pain, and altered bowel habits in patients with IBS, with the mechanism likely involving reduced fermentation and gas production.3 In the context of SIBO, low-FODMAP is best used as a short-term symptom management tool during antimicrobial treatment, not as a standalone cure. Prolonged restriction without reintroduction can negatively affect microbiome diversity.
Herbal Antimicrobials
A prospective study published in Global Advances in Health and Medicine compared herbal antimicrobial therapy using combinations including berberine, oregano oil, and other botanicals to rifaximin for the treatment of SIBO. The herbal protocol demonstrated equivalent efficacy to rifaximin in normalizing lactulose breath test results, with a favorable safety profile.4 Herbal antimicrobials are commonly used in functional medicine protocols, particularly for patients who prefer to avoid pharmaceutical antibiotics or who have not responded to standard rifaximin-based treatment.
Pharmaceutical and Compounded Approaches
Rifaximin remains the most studied pharmaceutical option for hydrogen-dominant SIBO, with neomycin often added for methane-dominant presentations. For patients whose clinical picture does not fit standard protocols, or who require specific dosing adjustments, compounded formulations offer a meaningful alternative. Patient-specific compounded antimicrobial preparations can be tailored to concentration, delivery form, and combination therapy in ways that commercially available products cannot accommodate.
The Customgut program at Customicro Clinical Services is built around this individualized approach, combining functional testing, targeted antimicrobial therapy, and motility support into a structured clinical framework designed to address SIBO at its root rather than simply suppressing symptoms.
Prokinetics and Motility Support
Addressing bacterial overgrowth without restoring MMC function is one of the most common reasons SIBO recurs. Prokinetic agents, including low-dose naltrexone, ginger-based preparations, and prescription motility agents, are used to support interdigestive gut contractions and reduce the bacterial accumulation that follows impaired clearance. This phase of treatment is often overlooked in standard protocols but is critical for long-term resolution.
Standard Approach
- +Single-course rifaximin without root-cause evaluation
- +Generic dietary advice without FODMAP guidance
- +No motility support after antimicrobial treatment
- +No follow-up breath testing to confirm eradication
- +High recurrence rate without addressing predisposing factors
Functional Clinical Approach
- +Breath testing to confirm SIBO type before treatment selection
- +Targeted antimicrobial protocol matched to hydrogen or methane pattern
- +Low-FODMAP dietary support during treatment phase
- +Prokinetic therapy to restore MMC function and prevent recurrence
- +Compounded formulations when standard dosing is insufficient
Getting the Right Care in Scottsdale
Chronic bloating and SIBO are not conditions you have to simply manage indefinitely. With the right diagnostic workup, a treatment protocol matched to your specific bacterial pattern, and attention to the root-cause factors driving recurrence, meaningful and lasting improvement is achievable.
For patients in Scottsdale and across the Phoenix metro area, access to functional gastrointestinal care, including compounded prescription options, is available locally. Customedico Pharmacy + Wellness works directly with prescribing providers to prepare patient-specific formulations for SIBO treatment, motility support, and microbiome restoration, supporting the full clinical protocol rather than just filling a standard prescription.
If you have been dealing with unexplained bloating, recurring digestive distress, or a previous SIBO diagnosis that has not fully resolved, the next step is a conversation with a provider who understands functional gut medicine. Ask about breath testing, discuss your history of food poisoning or antibiotic use, and explore whether a structured, individualized protocol is the right fit for your situation.
Partner With Us
Join our provider network
We partner directly with prescribing providers to deliver patient-specific compounded formulations for SIBO, motility support, and microbiome restoration. If you manage patients with chronic digestive conditions, we would like to support your practice. Access our provider portal to get started or explore the Customgut program.
Frequently Asked Questions
SIBO shares symptoms with IBS, Crohn's disease, and other functional gut disorders, which is why clinical testing is essential. Lactulose or glucose breath testing measuring hydrogen and methane gas is the most accessible diagnostic tool. A functional medicine provider or gastroenterologist can order the appropriate test and interpret results in the context of your full symptom picture.
Yes. SIBO recurrence is common, particularly when the underlying root cause, such as impaired migrating motor complex function, low stomach acid, or structural abnormalities, has not been addressed. A comprehensive treatment plan targets both the bacterial overgrowth and the conditions that allowed it to develop in the first place.
No. The low-FODMAP diet is a short-term symptom management tool, not a cure. It reduces fermentable substrates that feed bacteria in the small intestine, which can significantly reduce bloating and discomfort during treatment. Long-term restriction of FODMAPs without reintroduction can negatively affect microbiome diversity and is not recommended as a permanent dietary strategy.
Hydrogen-dominant SIBO is typically associated with diarrhea-predominant symptoms, while methane-dominant SIBO (now sometimes called intestinal methanogen overgrowth, or IMO) is more commonly linked to constipation. The distinction matters clinically because treatment protocols, including antimicrobial selection and dietary approach, differ between the two patterns.
Pharmaceutical antimicrobial treatment for SIBO, including rifaximin and neomycin, requires a valid prescription from a licensed healthcare provider. Compounded formulations tailored to your specific presentation also require a prescription. Herbal antimicrobial protocols do not require a prescription but should be supervised by a qualified clinician to ensure appropriate dosing and monitoring.
Yes. Customedico Pharmacy + Wellness serves patients and providers throughout Scottsdale and the greater Phoenix metro area with patient-specific compounded formulations for gastrointestinal conditions including SIBO. Compounded prescriptions can also be dispensed statewide with a valid provider order.
References
- 1.Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165-178.
- 2.Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11(2):196-208.
- 3.Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66(8):1517-1527.
- 4.Chedid V, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16-24.
- 5.Rezaie A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017;112(5):775-784.